美国成人CKD进展的个体化绝对风险评估
该研究利用1999-2020年NHANES数据,评估美国成人个体水平的3年CKD进展绝对风险(eGFR下降≥40%或肾衰竭),并将3年风险≥5%定义为高风险。
要点
- CKD G3a-A1患者中94%的3年进展风险低于5%。
核心结论
- 个体化绝对风险评估可对CKD患者进一步风险分层,并识别出不符合现有CKD定义但进展高风险的人群。
研究设计与样本
- 基于1999至2020年美国国家健康与营养调查(NHANES)数据,评估美国成人个体水平的3年CKD进展绝对风险。
- CKD进展定义为eGFR下降≥40%或肾衰竭,3年风险≥5%定义为高风险。
主要发现
- 199.81百万美国成人中,8.42百万(4%)3年风险≥5%,包括1.04百万无CKD者(eGFR≥60且白蛋白尿<30 mg/g)。
- 无CKD但高风险成人中,高血压占98%、心力衰竭占72%、糖尿病占44%。
- 15.51百万成人有eGFR保留的CKD(eGFR≥60且白蛋白尿≥30 mg/g),其中3.73百万3年风险≥5%,41%无糖尿病。
- 5.66百万CKD stage G3a-A1成人中,94%的3年进展风险<5%。
关键数值与推荐
- 3年CKD进展风险≥5%定义为高风险。
- CKD进展判定标准为eGFR下降≥40%或肾衰竭。
临床怎么用
- 对CKD患者应评估个体化3年绝对进展风险以辅助风险分层。
- 现有CKD定义可能遗漏部分高风险个体,需关注不符合CKD定义但3年风险≥5%者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: A total of 8.42 million US adults have high CKD progression risk, and 4.77 million of them have eGFR >60 ml/min per 1.73 m2. An individual's absolute risk of CKD progression is important in the diagnosis and prognostication of CKD. BACKGROUND: CKD is currently defined using GFR or albuminuria. This is on the basis of the relative risk of mortality and kidney outcomes compared with a healthy population and does not consider an individual's absolute risk of CKD progression. METHODS: Using National Health and Nutrition Examination Survey data from 1999 to 2020, we characterized the individual-level absolute 3-year risk of ≥40% decline in eGFR (ml/min per 1.73 m2) or kidney failure (3-year risk) among US adults. We categorized the 3-year risk and considered ≥5% as high risk. RESULTS: Among 199.81 million US adults, 8.42 million (4%) had a 3-year risk ≥5%, including 1.04 million adults without CKD (eGFR ≥60 and albuminuria <30 mg/g). These high-risk adults without CKD as currently defined had risk factors including hypertension (98%), heart failure (72%), and diabetes (44%). A total of 15.51 million adults had CKD with preserved eGFR (eGFR ≥60 and albuminuria ≥30 mg/g)—3.73 million had a 3-year risk ≥5%, 41% of whom did not have diabetes and thus would not be screened for albuminuria using current screening recommendations. The 3-year risk of CKD progression was low (risk <5%) in 94% of the 5.66 million US adults with CKD stage G3a-A1 (eGFR 45 to <60 and albuminuria <30 mg/g). CONCLUSIONS: Assessment of the individual's absolute risk of CKD progression allowed further risk stratification of patients with CKD and identified individuals without CKD, as currently defined, who were at high risk of CKD progression. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_06_18_ASN0000000000000377.mp3
引用
- Tio MC, Butler J, Zhu X, et al. Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024. PMID: 38749547. doi:10.1681/ASN.0000000000000377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。